new-vmware-vsphere-reporting-application

We’re pretty excited here at opvizor about our upcoming offering, a reporting only application based on our Health Analyzer for all folks out there, just want to get a vast amount of reports to document their environment or prepare troubleshooting and detect potential bottlenecks.

The application itself will be released this Summer, but we want to release the beta soon. Therefore please register here if you want to be part of our beta program of Reporter (will be limited and on a first come, first served basis) and be one of the first to use it:

Join Reporter Beta

To give you a better idea about the feature set and how the application looks like:

Create Reports as a Service

  • Network
  • Datastore
  • Health Check
  • Inventory
  • Snapshots
  • Security
  • Memory Usage
  • Memory Waste
  • vMotion/Storage vMotion
  • Change Management

VMware vSphere Reporter - VMware vSphere Reporting

RELATED ARTICLES

Save energy without reducing VM performance in your VMware vSphere cluster
16 August 2022
Over the last couple of decades energy consumption went up massively in every data center and while the…
Dennis
Metrics & Logs support for IoT - Bringing Secure Monitoring and Logging to the Edge
7 July 2022
Simple uptime monitoring for Internet-of-Things (IoT) is well-known and requires knowing if the devices are up and running.…
Dennis
Monitoring Azure SQL Managed Instance with Opvizor Metrics & Logs
17 January 2022
When you have critical applications and business processes that rely on Azure resources, it's critical to keep an…
Dennis

White Paper — Registration

You will receive the research paper by mail.

Codenotary — Webinar

White Paper — Registration

Please let us know where we can send the whitepaper on Codenotary Trusted Software Supply Chain. 

Become a partner

Start Your Trial

Please enter contact information to receive an email with the virtual appliance download instructions.

Start Free Trial

Please enter contact information to receive an email with the free trial details.

Subscribe to our newsletter